Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 7 M18 M4 M13 M21 M20 M 58 M Research & development —————— — Operating income 648 M788 M888 M646 M776 M1.01 B 3.32 B Non-Operating Income, Total -136 M-117 M-44 M-211 M-258 M-146 M -659 M Interest expense, net of interest capitalized 80 M90 M98 M98 M99 M101 M 396 M Non-Operating Income, excl. Interest Expenses -216 M-207 M-142 M-309 M-357 M-247 M -1.05 B Unusual income/expense —————— — Pretax income 369 M341 M320 M510 M441 M605 M 1.88 B Equity in earnings —————— — Taxes 81 M160 M65 M45 M110 M141 M 361 M Non-controlling/minority interest 2 M1 M2 M2 M1 M2 M 7 M After tax other income/expense —————— — Net income before discontinued operations 286 M180 M253 M463 M330 M462 M 1.51 B Discontinued operations —————— — Net income 286 M180 M253 M463 M330 M462 M 1.51 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 286 M180 M253 M463 M330 M462 M 1.51 B Basic earnings per share (Basic EPS) 4.332.723.857.075.047.07 23.03 Diluted earnings per share (Diluted EPS) 4.272.73.816.974.987.01 22.77 Average basic shares outstanding 66 M66 M66 M65.9 M65 M65 M — Diluted shares outstanding 67 M67 M67 M66.8 M66 M66 M — EBITDA 1.1 B1.22 B1.36 B1.15 B1.29 B1.51 B 5.31 B EBIT 648 M788 M888 M646 M776 M1.01 B 3.32 B Cost of revenue 4.54 B4.79 B5.37 B5.75 B5.61 B5.6 B 22.34 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 417 M433 M471 M500 M512 M508 M 1.99 B